GRAY vs. IBIO, AEON, OBSV, AEZS, NRBO, CPHI, SPRB, ORGS, MTNB, and NBY
Should you be buying Graybug Vision stock or one of its competitors? The main competitors of Graybug Vision include iBio (IBIO), AEON Biopharma (AEON), ObsEva (OBSV), Aeterna Zentaris (AEZS), NeuroBo Pharmaceuticals (NRBO), China Pharma (CPHI), Spruce Biosciences (SPRB), Orgenesis (ORGS), Matinas Biopharma (MTNB), and NovaBay Pharmaceuticals (NBY). These companies are all part of the "pharmaceutical preparations" industry.
Graybug Vision vs. Its Competitors
Graybug Vision (NASDAQ:GRAY) and iBio (NYSE:IBIO) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, dividends, analyst recommendations, valuation, earnings and media sentiment.
Graybug Vision has a beta of 1.2, meaning that its share price is 20% more volatile than the S&P 500. Comparatively, iBio has a beta of 0.94, meaning that its share price is 6% less volatile than the S&P 500.
iBio has a consensus price target of $5.00, suggesting a potential upside of 582.04%. Given iBio's stronger consensus rating and higher probable upside, analysts clearly believe iBio is more favorable than Graybug Vision.
49.9% of Graybug Vision shares are held by institutional investors. Comparatively, 7.9% of iBio shares are held by institutional investors. 7.9% of Graybug Vision shares are held by company insiders. Comparatively, 0.6% of iBio shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
In the previous week, Graybug Vision's average media sentiment score of 0.00 equaled iBio'saverage media sentiment score.
iBio has higher revenue and earnings than Graybug Vision.
iBio's return on equity of -73.15% beat Graybug Vision's return on equity.
Summary
iBio beats Graybug Vision on 7 of the 10 factors compared between the two stocks.
Get Graybug Vision News Delivered to You Automatically
Sign up to receive the latest news and ratings for GRAY and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding GRAY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Graybug Vision Competitors List
Related Companies and Tools
This page (NASDAQ:GRAY) was last updated on 7/26/2025 by MarketBeat.com Staff
